NASDAQ:PRVB - Provention Bio News Headlines

$10.05
-0.08 (-0.79 %)
(As of 09/16/2019 10:02 AM ET)
Today's Range
$9.95
Now: $10.05
$10.10
50-Day Range
$8.89
MA: $9.85
$11.35
52-Week Range
$1.52
Now: $10.05
$22.82
Volume6,876 shs
Average Volume296,498 shs
Market Capitalization$395.37 million
P/E RatioN/A
Dividend YieldN/A
Beta5.96

Headlines

Provention Bio (NASDAQ PRVB) News Headlines

Source:
DateHeadline
Short Interest in Provention Bio Inc (NASDAQ:PRVB) Rises By 42.0%Short Interest in Provention Bio Inc (NASDAQ:PRVB) Rises By 42.0%
www.americanbankingnews.com - September 12 at 6:25 PM
Zacks: Analysts Expect Provention Bio Inc (NASDAQ:PRVB) to Announce -$0.32 EPSZacks: Analysts Expect Provention Bio Inc (NASDAQ:PRVB) to Announce -$0.32 EPS
www.americanbankingnews.com - September 11 at 8:23 PM
Stock Traders Purchase High Volume of Call Options on Provention Bio (NASDAQ:PRVB)Stock Traders Purchase High Volume of Call Options on Provention Bio (NASDAQ:PRVB)
www.americanbankingnews.com - September 11 at 8:39 AM
 Provention Bio Inc (NASDAQ:PRVB) Given Consensus Rating of "Strong Buy" by Analysts Provention Bio Inc (NASDAQ:PRVB) Given Consensus Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - September 8 at 8:35 AM
Innovative Drug-Delivery Systems Benefit Patients and BusinessesInnovative Drug-Delivery Systems Benefit Patients and Businesses
www.finanznachrichten.de - September 4 at 8:46 AM
Need To Know: Provention Bio, Inc. (NASDAQ:PRVB) Insiders Have Been Buying SharesNeed To Know: Provention Bio, Inc. (NASDAQ:PRVB) Insiders Have Been Buying Shares
finance.yahoo.com - August 27 at 3:52 PM
Provention Bio Inc (NASDAQ:PRVB) Short Interest UpdateProvention Bio Inc (NASDAQ:PRVB) Short Interest Update
www.americanbankingnews.com - August 27 at 12:34 AM
Provention Bio strengthens leadership teamProvention Bio strengthens leadership team
seekingalpha.com - August 20 at 10:28 AM
Provention Bio Initiates Phase 1b/2a PREVAIL Clinical Trial Evaluating PRV-3279 in LupusProvention Bio Initiates Phase 1b/2a PREVAIL Clinical Trial Evaluating PRV-3279 in Lupus
finance.yahoo.com - August 8 at 9:02 AM
Provention Bio EPS misses by $0.01Provention Bio EPS misses by $0.01
seekingalpha.com - August 6 at 12:24 PM
Provention Bio Reports Second Quarter 2019 Financial ResultsProvention Bio Reports Second Quarter 2019 Financial Results
finance.yahoo.com - August 6 at 12:24 PM
A Look At Benzinga Pros Most-Searched Tickers For August 5, 2019A Look At Benzinga Pro's Most-Searched Tickers For August 5, 2019
finance.yahoo.com - August 5 at 3:52 PM
Provention Bios PRV-031 Breakthrough Therapy for individuals at risk type 1 diabetesProvention Bio's PRV-031 Breakthrough Therapy for individuals at risk type 1 diabetes
seekingalpha.com - August 5 at 11:31 AM
Provention Bio May Offer New Hope For People With Type 1 Diabetes With Latest Clinical DataProvention Bio May Offer New Hope For People With Type 1 Diabetes With Latest Clinical Data
seekingalpha.com - June 19 at 12:00 PM
Why Consistent Trading Doesnt Always Lead To Consistent ResultsWhy Consistent Trading Doesn't Always Lead To Consistent Results
finance.yahoo.com - June 14 at 7:32 PM
Provention Bio: The Panacea For DiabetesProvention Bio: The Panacea For Diabetes
seekingalpha.com - June 14 at 2:31 PM
Provention Bio's stock surges after calling off public stock offeringProvention Bio's stock surges after calling off public stock offering
finance.yahoo.com - June 13 at 3:48 PM
Provention Bio Cancels Secondary Offering, Shares RallyProvention Bio Cancels Secondary Offering, Shares Rally
finance.yahoo.com - June 13 at 3:48 PM
Provention Bios stock surges after calling off public stock offeringProvention Bio's stock surges after calling off public stock offering
www.marketwatch.com - June 13 at 8:56 AM
Provention Bio Announces Termination of Public Offering of Common StockProvention Bio Announces Termination of Public Offering of Common Stock
finance.yahoo.com - June 13 at 8:56 AM
Provention Bio's stock surges after calling off public stock offeringProvention Bio's stock surges after calling off public stock offering
finance.yahoo.com - June 13 at 8:56 AM
Provention Bio Announces Proposed Public Offering of Common StockProvention Bio Announces Proposed Public Offering of Common Stock
finance.yahoo.com - June 11 at 12:15 PM
Provention Bio Jumps 300% After Pipeline Asset Shows Efficacy In Delaying Onset Of Diabetes In At-Risk PatientsProvention Bio Jumps 300% After Pipeline Asset Shows Efficacy In Delaying Onset Of Diabetes In At-Risk Patients
www.msn.com - June 11 at 12:15 PM
Company News For Jun 11, 2019Company News For Jun 11, 2019
finance.yahoo.com - June 11 at 12:15 PM
Provention Bio up 176% premarket on potential of teplizumab to delay diabetesProvention Bio up 176% premarket on potential of teplizumab to delay diabetes
seekingalpha.com - June 10 at 12:24 PM
Could The Provention Bio, Inc. (NASDAQ:PRVB) Ownership Structure Tell Us Something Useful?Could The Provention Bio, Inc. (NASDAQ:PRVB) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - May 27 at 11:19 AM
Provention Bio Reports First Quarter 2019 Financial ResultsProvention Bio Reports First Quarter 2019 Financial Results
www.prnewswire.com - May 9 at 12:10 PM
Provention Bio Announces Top-Line Results from its Phase 1b PULSE Clinical Trial of PRV-300 in Patients with Moderate-to-Severe Ulcerative ColitisProvention Bio Announces Top-Line Results from its Phase 1b PULSE Clinical Trial of PRV-300 in Patients with Moderate-to-Severe Ulcerative Colitis
www.prnewswire.com - May 9 at 12:10 PM
The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stocks To DebutThe Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stocks To Debut
finance.yahoo.com - May 9 at 12:10 PM
Provention Bio Completes Enrollment of Phase 2a PRINCE Clinical Trial with PRV-6527 in Patients with Moderate to Severe Crohns DiseaseProvention Bio Completes Enrollment of Phase 2a PRINCE Clinical Trial with PRV-6527 in Patients with Moderate to Severe Crohn's Disease
finance.yahoo.com - April 24 at 12:04 PM
Provention Bio, Inc. (PRVB) Shares March Higher, Can It Continue?Provention Bio, Inc. (PRVB) Shares March Higher, Can It Continue?
finance.yahoo.com - April 12 at 12:58 PM
Provention Bio commences late-stage study of T1D candidate teplizumabProvention Bio commences late-stage study of T1D candidate teplizumab
seekingalpha.com - April 9 at 1:42 PM
Provention Bio Initiates Phase 3 PROTECT Clinical Trial with PRV-031 (Teplizumab) in Patients with Recent Onset Type 1 DiabetesProvention Bio Initiates Phase 3 PROTECT Clinical Trial with PRV-031 (Teplizumab) in Patients with Recent Onset Type 1 Diabetes
finance.yahoo.com - April 9 at 1:42 PM
Provention Bio Announces Key Additions to its Senior Management TeamProvention Bio Announces Key Additions to its Senior Management Team
finance.yahoo.com - April 2 at 11:52 AM
Provention Bio Appoints Jeffrey Bluestone, PhD, to Board of DirectorsProvention Bio Appoints Jeffrey Bluestone, PhD, to Board of Directors
finance.yahoo.com - March 28 at 12:08 PM
Provention Bios (PRVB) CEO Ashleigh Palmer on Q4 2018 Results - Earnings Call TranscriptProvention Bio's (PRVB) CEO Ashleigh Palmer on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 20 at 11:45 AM
Provention Bio, Inc.s (PRVB) CEO Ashleigh Palmer on Q4 2018 Results - Earnings Call TranscriptProvention Bio, Inc.'s (PRVB) CEO Ashleigh Palmer on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 20 at 11:45 AM
Provention Bio Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business UpdateProvention Bio Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
finance.yahoo.com - March 20 at 11:45 AM
Provention Bio IncProvention Bio Inc
www.bloomberg.com - March 19 at 8:17 AM
Provention Bio to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, March 19, 2019Provention Bio to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, March 19, 2019
finance.yahoo.com - March 12 at 8:45 PM
Provention Bio To Present at 8th Annual Leerink Partners Global Healthcare ConferenceProvention Bio To Present at 8th Annual Leerink Partners Global Healthcare Conference
finance.yahoo.com - February 13 at 10:34 AM
Provention Bio nabs patent for CVB vaccine in U.S.Provention Bio nabs patent for CVB vaccine in U.S.
seekingalpha.com - January 28 at 10:13 AM
Provention Bio Receives Notice of Allowance from United States Patent and Trademark Office for Patent on Multi-Strain Coxsackievirus B Vaccine for Preventing or Treating Type 1 Diabetes (T1D)Provention Bio Receives Notice of Allowance from United States Patent and Trademark Office for Patent on Multi-Strain Coxsackievirus B Vaccine for Preventing or Treating Type 1 Diabetes (T1D)
finance.yahoo.com - January 28 at 10:13 AM
Provention Bio Announces Publication in "Expert Review of Vaccines" Describing the Scientific Rationale for Developing a Vaccine for Type 1 Diabetes by Targeting Coxsackievirus BProvention Bio Announces Publication in "Expert Review of Vaccines" Describing the Scientific Rationale for Developing a Vaccine for Type 1 Diabetes by Targeting Coxsackievirus B
finance.yahoo.com - January 3 at 9:08 AM
Are Insiders Buying Provention Bio, Inc. (NASDAQ:PRVB) Stock?Are Insiders Buying Provention Bio, Inc. (NASDAQ:PRVB) Stock?
finance.yahoo.com - December 25 at 3:22 PM
Provention Bio Inc.Provention Bio Inc.
www.barrons.com - December 19 at 3:23 PM
Provention Bio Joins the C-Path Type 1 Diabetes (T1D) ConsortiumProvention Bio Joins the C-Path Type 1 Diabetes (T1D) Consortium
finance.yahoo.com - November 28 at 7:43 AM
Provention Bio Reports Third Quarter 2018 Financial Results and Provides Business UpdateProvention Bio Reports Third Quarter 2018 Financial Results and Provides Business Update
finance.yahoo.com - November 8 at 3:20 PM
Amgen (AMGN), Provention Bio (PRVB) Announce Co-Development Collaboration In Celiac DiseaseAmgen (AMGN), Provention Bio (PRVB) Announce Co-Development Collaboration In Celiac Disease
www.streetinsider.com - November 5 at 3:17 PM
Provention Bio up 12% on co-development deal with AmgenProvention Bio up 12% on co-development deal with Amgen
seekingalpha.com - November 5 at 3:17 PM
This page was last updated on 9/16/2019 by MarketBeat.com Staff

Featured Article: Call Option Volume

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel